Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome

Journal of the American Society of Nephrology

Volumn 17, Issue 7, 2006, Pages 2017-2025

  Fremeaux Bacchi, Véronique ^a,b   Moulton, Elizabeth A ^c   Kavanagh, David ^c   Dragon Durey, Marie Agnès ^a   Blouin, Jacques ^a   Caudy, Amy ^c   Arzouk, Nadia ^d   Cleper, Roxanna ^e   Francois, Maud ^f   Guest, Genevieve ^g   Pourrat, Jacques ^h   Seligman, Roland ⁱ   Fridman, Wolf Herman ^a,b   Loirat, Chantal ^j   Atkinson, John P ^c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSERM   (France)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BICÊTRE HOSPITAL   (France)

^e TEL AVIV UNIVERSITY   (Israel)

^f CHU BRETONNEAU   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h TOULOUSE UNIVERSITY HOSPITAL   (France)

ⁱ CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^j HÔPITAL ROBERT DEBRÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; MEMBRANE COFACTOR PROTEIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; KIDNEY BLOOD VESSEL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PEDIGREE; PENETRANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; REGULATORY MECHANISM; RISK FACTOR; SCHOOL CHILD; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 33745812440     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005101051     Document Type: Article

References (33)

1. Moake JL: Thrombotic microangiopathies. N Engl J Med 347: 589-600, 2002
2. Ruggenenti P, Noris M, Remuzzi G: Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60: 831-846, 2001
3. Tarr PI, Gordon CA, Chandler WL: Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073-1086, 2005
4. Noris M, Remuzzi G: Hemolytic uremic syndrome. J Am Soc Nephrol 16: 1035-1050, 2005
5. Caprioli J, Bettinaglio P, Zipfel PF, Amadei B, Daina E, Gamba S, Skerka C, Marziliano N, Remuzzi G, Noris M: The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 12: 297-307, 2001
6. Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, Vigneau C, Kuypers D, Boudailliez B, Loirat C, Rondeau E, Fridman WH: Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41: 1-5, 2004
7. Kavanagh D, Kemp EJ, Mayland E, Winney RJ, Duffield JS, Warwick G, Richards A, Ward R, Goodship JA, Goodship TH: Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol 16: 2150-2155, 2005
8. Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, Gamba S, Remuzzi G: Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362: 1542-1547, 2003
9. Perez-Caballero D, Gonzalez-Rubio C, Gallardo ME, Vera M, Lopez-Trascasa M, Rodriguez de Cordoba S, Sanchez-Corral P: Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 68: 478-484, 2001
10. Richards A, Buddles MR, Donne RL, Kaplan BS, Kirk E, Venning MC, Tielemans CL, Goodship JA, Goodship TH: Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet 68: 485-490, 2001
11. Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Muslumanoglu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship TH: Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 100: 12966-12971, 2003
12. Warwicker P, Goodship TH, Donne RL, Pirson Y, Nicholls A, Ward RM, Turnpenny P, Goodship JA: Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53: 836-844, 1998
13. Fremeaux-Bacchi V, Kemp EJ, Goodship JA, Dragon-Durey MA, Strain L, Loirat C, Deng HW, Goodship TH: The development of atypical HUS is influenced by susceptibility factors in factor H and membrane cofactor protein: Evidence from two independent cohorts. J Med Genet 42: 852-856, 2005
14. Neumann HP, Salzmann M, Bohnert-Iwan B, Mannuelian T, Skerka C, Lenk D, Bender BU, Cybulla M, Riegler P, Konigsrainer A, Neyer U, Bock A, Widmer U, Male DA, Franke G, Zipfel PF: Haemolytic uraemic syndrome and mutations of the factor H gene: A registry-based study of German speaking countries. J Med Genet 40: 676-681, 2003
15. Esparza-Gordillo J, Goicoechea de Jorge E, Buil A, Berges LC, Lopez-Trascasa M, Sanchez-Corral P, Rodriguez de Cordoba S: Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 14: 1107, 2005
16. Manuelian T, Hellwage J, Meri S, Caprioli J, Noris M, Heinen S, Jozsi M, Neumann HP, Remuzzi G, Zipfel PF: Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 111: 1181-1190, 2003
17. Sanchez-Corral P, Perez-Caballero D, Huarte O, Simckes AM, Goicoechea E, Lopez-Trascasa M, de Cordoba SR: Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am J Hum Genet 71: 1285-1295, 2002
18. Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP: Control of the complement system. Adv Immunol 61: 201-283, 1996
19. Walport MJ: Complement. First of two parts. N Engl J Med 344: 1058-1066, 2001
20. Dragon-Durey MA, Fremeaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschenes G, Coppo P, Herman Fridman W, Weiss L: Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases. J Am Soc Nephrol 15: 787-795, 2004
21. Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Fremeaux-Bacchi V: Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16: 555-563, 2005
22. Liszewski MK, Leung M, Cui W, Subramanian VB, Parkinson J, Barlow PN, Manchester M, Atkinson JP: Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J Biol Chem 275: 37692-37701, 2000
23. Jeanpierre M: A rapid method for the purification of DNA from blood. Nucleic Acids Res 15: 9611, 1987
24. Liszewski MK, Tedja I, Atkinson JP: Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains. J Biol Chem 269: 10776-10779, 1994
25. Liszewski MK, Leung MK, Atkinson JP: Membrane cofactor protein: Importance of N- and O-glycosylation for complement regulatory function. J Immunol 161: 3711-3718, 1998
26. Post TW, Liszewski MK, Adams EM, Tedja I, Miller EA, Atkinson JP: Membrane cofactor protein of the complement system: Alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 174: 93-102, 1991
27. Krych M, Hauhart R, Atkinson JP: Structure-function analysis of the active sites of complement receptor type 1. J Biol Chem 273: 8623-8629, 1998
28. Ruggenenti P: Post-transplant hemolytic-uremic syndrome. Kidney Int 62: 1093-1104, 2002
29. Loirat C, Niaudet P: The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 18: 1095-1101, 2003
30. Goodship TH, Fremeaux-Bacchi V, Atkinson JP: Genetic testing in atypical HUS and the role of membrane cofactor protein (MCP; CD46) and Factor I. In: Complement and Kidney Disease, edited by Zipfel PF, Basel, Birkhauser Verlag, 2005, pp 111-127
31. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H: A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287: 498-501, 2000
32. Caprioli J, Castelletti F, Bucchioni S, Bettinaglio P, Bresin E, Pianetti G, Gamba S, Brioschi S, Daina E, Remuzzi G, Noris M: Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 12: 3385-3395, 2003
33. Esparza-Gordillo J, Jorge EG, Garrido CA, Carreras L, Lopez-Trascasa M, Sanchez-Corral P, de Cordoba SR: Insights into hemolytic uremic syndrome: Segregation of three independent predisposition factors in a large, multiple affected pedigree. Mol Immunol 43: 1769-1775, 2006